HF/Transplantation

Top Story

Dapagliflozin may improve lung fluid volume in HF

Dapagliflozin may improve lung fluid volume in HF
January 17, 2020

Read the Perspective from Elise Brett, MD

In the Journals

Region-specific gaps persist in acute HF management

January 16, 2020
Patients from several regions across the world present similarly with acute HF, but differences were observed regarding the type and timing of treatment, according to a…
In the Journals

Malignant LV hypertrophy may help explain elevated HF incidence in black population

January 16, 2020
Malignant left ventricular hypertrophy, a subtype in which patients have elevations in cardiac biomarkers associated with risk for HF, is more common in black…
Trial Scorecards

PIONEER-OLE

Cardiology Today, January 2020
Safety and efficacy of mavacamten (MyoKardia) in patients with obstructive hypertrophic cardiomyopathy.
More Headlines »